Semin Thromb Hemost 2019; 45(05): 429-432
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA. Editorial Compilation VII
Emmanuel J. Favaloro
1
Department of Haematology, Sydney Centers for Thrombosis and Haemostasis, Institute
of Clinical Pathology and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW,
Australia
,
Giuseppe Lippi
2
Section of Clinical Biochemistry, University of Verona, Verona, Italy
› Institutsangaben
References
1
Favaloro EJ.
2011 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2011; 37 (05) 431-439
2
Favaloro EJ.
2012 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2012; 38 (05) 425-432
3
Favaloro EJ.
2013 Eberhard F. Mammen award announcements. Semin Thromb Hemost 2013; 39 (06) 567-574
4
Favaloro EJ.
2014 Eberhard F. Mammen award announcements: part II-Young Investigator Awards. Semin
Thromb Hemost 2014; 40 (07) 718-723 5
Favaloro EJ.
2015 Eberhard F. Mammen award announcements: part II-Young Investigator Awards. Semin
Thromb Hemost 2015; 41 (08) 809-815 6
Favaloro EJ.
2016 Eberhard F. Mammen award announcements: part II-Young Investigator Awards. Semin
Thromb Hemost 2017; 43 (03) 235-241 7
Favaloro EJ.
2017 Eberhard F. Mammen award announcements: Part II-Young Investigator Awards. Semin
Thromb Hemost 2018; 44 (02) 81-88 8
Favaloro EJ.
2018 Eberhard F. Mammen award announcements: Part II-Young Investigator Awards. Semin
Thromb Hemost 2019; 45 (02) 123-129 9
Gosselin RC,
Marlar RA.
Pre-analytical variables in coagulation testing: setting the stage for accurate results.
Semin Thromb Hemost 2019; 45 (05) 433-448 10
Konstantinidi A,
Sokou R,
Parastatidou S.
, et al. Clinical application of thromboelastography/thromboelastometry (TEG/TEM)
in the neonatal population: a narrative review. Semin Thromb Hemost 2019; 45 (05)
449-457 11
Ames PRJ,
Bucci T,
Iannaccone L,
Marottoli V,
Arcaro A,
Gentile F,
Ciampa A.
Validity of coagulation activation markers in antiphospholipid syndrome: a systematic
review and meta-analysis with a short report. Semin Thromb Hemost 2019; 45 (05) 458-467
12
Lippi G,
Favaloro EJ.
Preanalytical issues in hemostasis and thrombosis testing. Methods Mol Biol 2017;
1646: 29-42 13
Favaloro EJ,
Lippi G.
Translational aspects of developmental hemostasis: infants and children are not miniature
adults and even adults may be different. Ann Transl Med 2017; 5 (10) 212 14
Hvas AM,
Favaloro EJ.
Platelet function testing in pediatric patients. Expert Rev Hematol 2017; 10 (04)
281-288 15
Tufano A,
Di Minno MND,
Guida A,
Lembo M,
Di Minno G,
Galderisi M.
Cardiac manifestations of antiphospholipid syndrome: clinical presentation, role of
cardiac imaging, and treatment strategies. Semin Thromb Hemost 2019; 45 (05) 468-477
16
Christiansen M,
Grove EL,
Hvas A-M.
Primary prevention of cardiovascular events with aspirin towards more harm than benefit:
a systematic review and meta-analysis. Semin Thromb Hemost 2019; 45 (05) 478-489 17
Lippi G,
Danese E,
Favaloro EJ.
Harms and benefits of using aspirin for primary prevention of cardiovascular disease:
a narrative overview. Semin Thromb Hemost 2019; 45 (02) 157-163 18
Lippi G,
Gosselin R,
Favaloro EJ.
Current and emerging direct oral anticoagulants (DOACs): state-of-the-art. Semin Thromb
Hemost 2019; 45 (05) 490-501 19
Lippi G,
Franchini M,
Favaloro EJ.
Pharmacogenetics of vitamin K antagonists: useful or hype?. Clin Chem Lab Med 2009;
47 (05) 503-515 20
Baluwala I,
Favaloro EJ,
Pasalic L.
Therapeutic monitoring of unfractionated heparin - trials and tribulations. Expert
Rev Hematol 2017; 10 (07) 595-605 21
McCaughan GJB,
Favaloro EJ,
Pasalic L,
Curnow J.
Anticoagulation at the extremes of body weight: choices and dosing. Expert Rev Hematol
2018; 11 (10) 817-828 22
Gosselin RC,
Adcock DM,
Bates SM.
, et al. International Council for Standardization in Haematology (ICSH) recommendations
for laboratory measurement of direct oral anticoagulants. Thromb Haemost 2018; 118
(03) 437-450 23
Lippi G,
Favaloro EJ.
Recent guidelines and recommendations for laboratory assessment of the direct oral
anticoagulants (DOACs): is there consensus?. Clin Chem Lab Med 2015; 53 (02) 185-197
24
DeLoughery E,
Olson SR,
McCarty OJT,
Shatzel JJ.
The safety and efficacy of novel agents targeting factor XI and XII in early phase
human trials. Semin Thromb Hemost 2019; 45 (05) 502-508 25
Horstman LL,
McCauley RF,
Jy W,
Ahn YS.
Tissue factor-negative cell-derived microparticles play a distinctive role in hemostasis:
a viewpoint review. Semin Thromb Hemost 2019; 45 (05) 509-513 26
de Mello C,
Loures G,
Figueiredo Duarte RC.
, et al. Hemostatic abnormalities in dementia: a systematic review and meta-analysis.
Semin Thromb Hemost 2019; 45 (05) 514-522 27
Tabibian S,
Shiravand Y,
Shams M.
, et al. A comprehensive overview of coagulation factor V and congenital factor V
deficiency. Semin Thromb Hemost 2019; 45 (05) 523-543 28
Lippi G,
Danese E,
Favaloro EJ.
Vascular disease and dementia: lipoprotein(a) as a neglected link. Semin Thromb Hemost
2019; 45 (05) 544-547 29
Zuo H,
Yang F,
Hu Y.
Investigation of possible herb – drug interactions for the treatment of cardiovascular
diseases. Semin Thromb Hemost 2019; 45 (05) 548-551 30
McEwen BJ.
Comment on “Investigation of possible herb – drug interactions for the treatment of
cardiovascular diseases”. Semin Thromb Hemost 2019; 45 (05) 552-553 31
Ruiz-Argüelles GJ.
Comment on: Inherited thrombophilia and pregnancy complications: should we test?.
Semin Thromb Hemost 2019; 45 (05) 554-554 32
Arachchillage DRJ,
Makris M.
Reply to comment on: Inherited thrombophilia and pregnancy complications: Should we
test?. Semin Thromb Hemost 2019; 45 (05) 555-556
